Table 1.
+, agree but no consensus; *, agree with consensus; **, strongly agree with consensus
| Harmonisation | |
| One acquisition protocol should be created to cover all quantitative (response) assessment of metastatic disease (“one size fits all”) | * |
| Define Matrix size | + |
| Define Slice thickness | * |
| Define fat suppression technique | * |
| Define minimum number of b-values | * |
| Define min/max b-values | * |
| Whole body (head to mid-thigh) | * |
| It should be possible to do quantitative (response) assessment on data from different scanners of the same manufacturer/model | ** |
| It should be possible to do quantitative (response) assessment on data from different scanners of different manufacturers | * |
| An appropriately trained person should always perform a set up optimisation with a suitable test object. | ** |
| A regular QC test should be carried out with a suitable test object. | ** |
| It should be possible to define a post-processing pipeline that allows any ADC map from any scanner to be compared. | ** |
ADC, apparent diffusion coefficient; QC, quality control;